WWM
MRNA icon

Wolff Wiese Magana’s Moderna MRNA Stock Holding History

Wolff Wiese Magana’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-20
Closed -$552 – 1016
2025
Q2 		$552 Buy
20
+5
+33% +$132 ﹤0.01% 901
2025
Q1 		$426 Buy
+15
New +$532 ﹤0.01% 931
2024
Q3 		– Sell
-5
Closed -$594 – 1008
2024
Q2 		$594 Hold
5
– – ﹤0.01% 691
2024
Q1 		$533 Sell
5
-20
-80% -$2.02K ﹤0.01% 631
2023
Q4 		$2.49K Sell
25
-12
-32% -$1.01K ﹤0.01% 453
2023
Q3 		$3.82K Sell
37
-5
-12% -$558 ﹤0.01% 471
2023
Q2 		$5.1K Hold
42
– – ﹤0.01% 443
2023
Q1 		$6.45K Hold
42
– – 0.01% 404
2022
Q4 		$7.54K Sell
42
-10
-19% -$1.64K 0.01% 360
2022
Q3 		$6K Buy
52
+10
+24% +$1.52K ﹤0.01% 579
2022
Q2 		$6K Sell
42
-4
-9% -$572 ﹤0.01% 615
2022
Q1 		$8K Hold
46
– – 0.01% 574
2021
Q4 		$12K Sell
46
-106
-70% -$31K 0.01% 515
2021
Q3 		$58K Buy
152
+76
+100% +$28K 0.04% 256
2021
Q2 		$18K Buy
76
+9
+13% +$1.61K 0.01% 411
2021
Q1 		$9K Hold
67
– – 0.01% 496
2020
Q4 		$7K Buy
+67
New +$6.78K 0.01% 493

Other funds holding MRNA

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.5B AUM 19.72% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Wolff Wiese Magana's MRNA Position: Q3 2025 in Review

Wolff Wiese Magana sold out of Moderna (MRNA) in Q3 2025, closing a stake of 20 shares — an estimated $552 sold.

Wolff Wiese Magana first reported a position in MRNA in Q4 2020 and held it in 17 quarters. The position peaked at $58K in Q3 2021. 643 funds tracked by Wall St. Rank hold MRNA as of Q3 2025.

  • Wolff Wiese Magana reported no remaining Moderna position as of Q3 2025 after selling out during the quarter.
  • Wolff Wiese Magana sold 20 Moderna shares in Q3 2025, an estimated $552.
  • Wolff Wiese Magana first reported a position in Moderna in Q4 2020 and held it in 17 quarters.
  • Wolff Wiese Magana's Moderna position peaked at $58K in Q3 2021.
  • 643 funds tracked by Wall St. Rank held Moderna as of Q3 2025.

Based on Wolff Wiese Magana's 13F filing for Q3 2025, filed 28 Oct 2025.